Paroxetine hydrochloride hemihydrate
CAS: 110429-35-1
Rif. IN-DA00ILQO
| 1g | Fuori produzione | ||
| 5g | Fuori produzione | ||
| 25g | Fuori produzione | ||
| 250mg | Fuori produzione |
Informazioni sul prodotto
Nome:
Paroxetine hydrochloride hemihydrate
Sinonimi:
- [u'Aropax', u'BRL 29060', u'BRL-29060', u'BRL29060', u'FG 7051', u'FG-7051', u'FG7051', u'Paroxetine', u'Paroxetine Acetate', u'Paroxetine Hydrochloride', u'Paroxetine Hydrochloride Anhydrous', u'Paroxetine Maleate', u'Paroxetine, cis-(+)-Isomer', u'Paroxetine, cis-(-)-Isomer', u'Paroxetine, trans-(+)-Isomer', u'Paxil', u'Seroxat', u'Paroxetine hydrochloride', u'Paroxetine Hcl', u'78246-49-8', u'Paxil', u'Paroxat', u'paroxetine (hydrochloride)', u'Aropax 20', u'(3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride', u'110429-35-1', u'BRL 29060 hydrochloride', u'UNII-3I3T11UD2S', u'Aropax', u'Paroxetine hydrochloride [USP]', u'BRL29060A', u'BRL 29060A', u'SDB 7175', u'3I3T11UD2S', u'Paroxetine hydrochloride hemihydrate (MW = 374.83)', u'HSDB 7175', u'S3005', u'C19H21ClFNO3', u'Paxil (TN)', u'Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3S,4R)-', u'Paroxetine hydrochloride (USP)', u'CHEMBL1708', u'(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine hydrochloride', u'(3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride', u'(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)-methyl)piperidine hydrochloride', u'(3S-TRANS)-3-[(1,3-BENZODIOXOL-5-YLOXY)METHYL]-4-(4-FLUOROPHENYL)PIPERIDINE HYDROCHLORIDE', u'Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3S-trans)-', u'FG-7051', u'paroxatene', u'Paroxetine hydrochloride [USAN]', u'Paroxetine, HCl', u'AK-49032', u'paroxetine (Paxil)', u'MFCD03658863', u'AC1L1XYV', u'BRL29060 hydrochloride', u'C19H20FNO3.HCl', u'SCHEMBL33348', u'MLS002222322', u'PAROXETIN HYDROCHLORIDE', u'SPECTRUM1504085', u'CHEBI:7944', u'KS-00000JOT', u'DTXSID50228914', u'GELRVIPPMNMYGS-RVXRQPKJSA-N', u'BRL-29060A', u'HMS1922B11', u'Pharmakon1600-01504085', u'(-)-trans-paroxetine hydrochloride', u'(S)-3-(BENZO[1,3]DIOXOL-5-YLOXYMETHYL)-4-(4-FLUORO-PHENYL)-PIPERIDINE HYDROCHLORIDE', u'HY-B0492', u'Tox21_500095', u'ANW-49202', u'BG0380', u'CCG-39866', u'NSC758654', u'AKOS015849162', u'AKOS015907108', u'API0003757', u'CS-2611', u'H29P351', u'KS-5097', u'LP00095', u'NSC-758654', u'YF10047', u'(3S,4R)-(-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride', u'NCGC00093597-01', u'NCGC00260780-01', u'AN-15600', u'BR-49032', u'SMR001307264', u'AB0008509', u'AB1004558', u'AX8022605', u'LS-114251', u'TC-137947', u'TL8005348', u'EU-0100095', u'P1977', u'ST24025708', u'SW197457-4', u'D05374', u'J10285', u'Paroxetine or other medication - algorithm used', u'S-2491', u'110429-35-1(hemihydrate) 61869-08-7', u'SR-01000759305', u'SR-01000759305-6', u'Z1741971218', u'(-)-trans-4-(-4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-piperidine hydrochloride', u'(-)-trans-4-(-4-fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-piperidine hydrochloride', u'(-)-trans-4-(4-fluorophenyl)-3-(3,4-methylene dioxyphenoxymethyl)-piperidine hydrochloride', u'(3S,4R)-3-((BENZO[D][1,3]DIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)PIPERIDINE HCL']
- (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine hydrochloride hemihydrate
- (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride (1:1)
- (3s-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride Hemihydrate
- (4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride (1:1)
- Paroxetine-D4 Hcl
- Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, hydrate (2:1), (3S,4R)-
- Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, hydrate (2:1), (3S-trans)-
- Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, hydrate (2:2:1), (3S,4R)-
- paroxetine hydrochloride Hemihydrate
- Vedi altri sinonimi
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Indagoo
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
749.6680
Formula:
C38H44Cl2F2N2O7
Purezza:
98%
Colore/Forma:
Solid
InChI:
InChI=1S/C19H20FNO3.ClH/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18;/h1-6,9,14,17,21H,7-8,10-12H2;1H/t14-,17-;/m0./s1
InChI key:
GELRVIPPMNMYGS-RVXRQPKJSA-N
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
